Jun 08, 2026
19 MIN READ

What Are the Doses of Tirzepatide? A Detailed Look at Dosage and Use

Tirzepatide dosing follows a stepwise titration schedule designed to minimize side effects while building metabolic benefit. PlexusDx offers compounded tirzepatide injections starting at $249 per month with personalized dosing guidance.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 08, 2026
19 MIN READ

what are the doses of tirzepatide? a detailed look at dosage and use — PlexusDx GLP-1 education

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide represents a dual-action GLP-1 and GIP receptor agonist that requires careful dose escalation to achieve optimal weight loss and metabolic outcomes. Unlike fixed-dose medications, tirzepatide treatment typically begins at a low dose and increases every four weeks based on tolerability and clinical response. Understanding how tirzepatide dosing works helps patients and providers make informed decisions about treatment initiation and progression.

Standard Tirzepatide Starting Doses and Titration Schedule

Tirzepatide treatment typically begins with a 2.5 mg weekly injection dose during week one through week four. This introductory dose allows the body to adapt to the medication while minimizing gastrointestinal discomfort and other adjustment-related side effects. Many patients report improved tolerability when starting at this conservative dose rather than beginning at higher levels.

After the first four weeks, the dose advances to 5 mg weekly for weeks five through eight in most treatment protocols. This doubling of the initial dose provides increased metabolic signaling without creating abrupt physiological changes. Patients who experience significant side effects at this level may remain on 5 mg for an additional four weeks before attempting further increases.

The eight-week mark typically brings the next scheduled increase to 7.5 mg weekly, which many patients tolerate well as a maintenance level. Clinical experience shows that 7.5 mg weekly produces meaningful weight reduction for a substantial portion of the population seeking GLP-1 therapy. Some patients achieve their weight loss goals at this dose and remain on it long-term without requiring further escalation.

Higher Maintenance Doses of Tirzepatide: 10 mg and 15 mg

Patients who continue to benefit from dose escalation typically progress to 10 mg weekly around week twelve of treatment. This dose level demonstrates enhanced metabolic effects compared to lower doses while maintaining acceptable safety profiles in clinical trials. The 10 mg dose represents the threshold where many patients begin experiencing maximal weight reduction trajectories.

The maximum approved dose of tirzepatide reaches 15 mg weekly, typically achieved after sixteen weeks of consistent titration. Only patients who demonstrate tolerability at each preceding dose level advance to 15 mg, ensuring that the medication remains safe and effective. Research indicates that 15 mg weekly produces the most substantial weight loss results, with some patients experiencing reductions exceeding 20 percent of baseline body weight.

Dose selection between 10 mg and 15 mg depends on individual factors including gastrointestinal tolerance, metabolic response, weight loss trajectory, and patient-reported side effects. Some patients plateau at 10 mg with excellent results, while others require 15 mg to achieve their therapeutic goals. PlexusDx providers assess these individual factors to determine the optimal maintenance dose for each patient's needs.

How Genetic Factors Influence Tirzepatide Dosing Requirements

Individual genetic variations significantly affect how different doses of tirzepatide influence weight loss, metabolic rate, and gastrointestinal response. The GIP receptor gene (GIPR rs1800437) and GLP-1 receptor gene (GLP1R rs6923761) represent critical genetic markers that predict differential medication response across the tirzepatide dose range. Patients carrying specific genetic variants may achieve optimal outcomes at lower doses, while others require higher doses to activate the same metabolic pathways.

The FTO gene variant (rs9939609) and MC4R gene variant (rs17782313) further refine the picture of how genetic predisposition shapes tirzepatide effectiveness and tolerability at various dose levels. Individuals with certain FTO genotypes may experience faster satiety and reduced appetite at standard doses, potentially achieving weight loss goals without escalating beyond 7.5 or 10 mg weekly. Conversely, patients with other genetic profiles may require the full 15 mg dose to achieve comparable metabolic suppression.

PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that maps 14 pathways, 49 peptides, and 150+ genetic insights specific to GLP-1 and GIP signaling. This genetic analysis, available at $99 per patient after the first month of treatment, helps optimize tirzepatide dosing by identifying which dose levels align with each patient's genetic metabolic profile. Personalized dosing based on genetic data may improve outcomes while reducing unnecessary side effects from excessive dosing.

Tirzepatide Dosing at PlexusDx: Flat-Rate Pricing Regardless of Dose Level

PlexusDx provides compounded tirzepatide injections from licensed 503A compounding pharmacies at a flat monthly rate of $249, regardless of whether a patient takes 2.5 mg or 15 mg weekly. This pricing structure means patients experience no additional costs when their healthcare provider determines that dose escalation improves their clinical outcomes. The flat-rate model removes financial barriers to optimal dosing and encourages providers to recommend the most effective dose for each patient.

Patients can initiate tirzepatide therapy with PlexusDx without requiring insurance approval, membership fees, or prior authorization delays that often slow down treatment initiation elsewhere. HSA and FSA accounts qualify for coverage, providing additional cost-saving opportunities for eligible patients. PlexusDx serves all 50 states, making high-quality compounded tirzepatide accessible to patients nationwide regardless of geographic location or insurance status.

The absence of flat per-compound pricing variations distinguishes PlexusDx from many traditional pharmaceutical models where higher doses command proportionally higher costs. This approach aligns patient interest with clinical interest, as both benefit when providers select the most effective dose rather than the cheapest dose. Patients can focus entirely on tolerability and efficacy rather than worrying about price increases accompanying dose increases.

Monitoring and Adjusting Tirzepatide Doses Throughout Treatment

Effective tirzepatide management requires regular check-ins to assess weight loss trajectory, gastrointestinal symptoms, and metabolic markers at each dose level. Providers typically schedule follow-up appointments at two-week intervals during the initial titration phase to ensure patients tolerate each dose increase appropriately. These frequent monitoring intervals help catch problematic side effects early and prevent unnecessary escalation for patients who achieve their goals at lower doses.

Some patients require extended time at a particular dose level before advancing further, a strategy known as extended titration that improves long-term tolerability and persistence with treatment. Providers may pause dose escalation for four to eight weeks if a patient experiences significant nausea, vomiting, or other gastrointestinal effects, allowing natural adaptation before attempting the next increase. Clinical evidence supports this flexible approach, showing improved treatment satisfaction and lower discontinuation rates when dosing timelines adapt to individual tolerance.

Weight loss patterns, appetite suppression, energy levels, and quality of life improvements guide decisions about optimal maintenance doses for each patient. Patients who achieve their target weight and maintain satiety at 10 mg weekly may not benefit from further escalation to 15 mg, potentially avoiding unnecessary side effects while maintaining excellent results. Ongoing assessment ensures tirzepatide dosing remains personalized to each patient's evolving needs throughout their treatment course.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What dose should I start with if I'm beginning tirzepatide for the first time?

Most patients begin with 2.5 mg weekly, the lowest available starting dose designed to allow your body to adjust while minimizing early side effects. PlexusDx providers assess your individual health status and recommend a starting dose tailored to your specific situation, always prioritizing tolerability during the initial treatment phase.

How long does it take to reach the maximum 15 mg dose of tirzepatide?

Standard titration protocols advance the dose every four weeks, meaning patients typically reach 15 mg after approximately 16 weeks if they tolerate each increase without significant side effects. However, individual timelines vary based on tolerability and clinical response, and some patients achieve excellent results without ever needing the maximum dose.

Does my price increase when my tirzepatide dose goes up?

No. PlexusDx charges a flat $249 per month for compounded tirzepatide injections regardless of your dose level. Your dose may need to go up based on your clinical response, but your price won't increase—a commitment to keeping treatment affordable as your therapy optimizes.

What if I experience side effects at my current tirzepatide dose?

Contact your PlexusDx provider immediately to discuss your symptoms. Many side effects improve with time or by remaining at the same dose longer before escalating, while others may require dose reduction or medication adjustment. Your provider may recommend dietary modifications, hydration strategies, or other supportive measures before considering dose changes.

How can genetic testing help optimize my tirzepatide dosing?

PlexusDx offers the Precision Peptide Genetic Test ($99 after your first treatment month) to identify your genetic profile across GLP-1 and GIP signaling pathways. This testing reveals which tirzepatide dose levels align best with your genetic predisposition, potentially helping you achieve optimal results at lower doses or informing decisions about when to escalate to higher doses.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves